维普中文期刊产品整合服务
75篇 您的检索式:作者名="Pauta"
    题名 作者 年代 出处 被引量
1Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701):a randomised,open-label,phase 3 study显示文摘Castaigne S Pautas C Terre C 0,,9825:1
2Genetic factors ( VKORC1, CYP2C9, EPHX1, and CYP4F2 ) are predictor variables for warfarin response in very elderly, frail inpatients显示文摘Pautas E Moreau C Gouin-Thibault I 2010Clin Pharmacol Ther2010,87,:1
3Randomized Study of for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years:Results of the ALFA-9801 Study 显示文摘Pautas C Merabet F Thomas Intensified Anthracycline Doses X 2010J Clin Oncol2010,28,5:1
4Superior long-term outeome with Idarubicin compared with high-dose Daunorubicin in patients with acute myeloid leukemia age 50 years and older 显示文摘Gardin C Chevret S Pautas C 2013J Clin Oncol2013,31,3:1
5Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes显示文摘Costa JM Pautas C Emauh P 2000J Clin Microbiol2000,38,8:1
6Effect of gemtuzumab ozo- gamicin on survival of adult patients with de-novo acute myeloid leukaemia(ALFA-0701):a randomized,open-label,phase 3 study显示文摘Castaigne S Pautas C Terre C 2012Lancet2012,379,9825:1
7Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia( AI- FA-0701 ) : a randomised, open-label, phase 3 study 显示文摘Castaigne S Pautas C Terre C 2012Lancet2012,379,9825:1
8Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years:results of the ALFA-9801 study 显示文摘Pautas C Merabet F Thomas X 2010J Clin Oncol2010,28,5:1
9Acute myeloid leukemia after infliximab:a case report显示文摘Kemta-Lekpa F Zahra K Pautas C 2009Clin Exp Rheumatol2009,27,9:1
10Micro satellite instability and frame shift mutations in BAX and transforming growth factor-βreceptorⅡgene are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines显示文摘Molenaar JJ Gerard B Pautas CC 1998Blood1998,92,1:1
11Mir-33 regulates cell proliferation and cell cycle progression 显示文摘CIRERA-SALINAS D PAUTA M ALLEN R M 2012Cell Cycle2012,11,5:1
12Cytochrome P450 2C9 polymorphisms (CYP2C9) and warfarin maintenance dose in elderly patients显示文摘Siguret V Gouin I Golmard JL Geoffroy S Andreux JP Pautas E 2004Revue de Medecine Interne2004,25,:1
13Apelin mediates the induction of profi?brogenic genes in human hepatic stellate cells 显示文摘Melgar - Lesmes P Casals G Pauta M 2010Endocrinology2010,151,11:1
14Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients显示文摘Pautas E Moreau C Gouin-Thibault I 2010Clin Pharmacol Thera2010,87,1:1
15Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2for maintenance in patients with acute myeloid leukemia age 50to 70years:results of the ALFA-9801study显示文摘Pautas C Merabet F Thomas X 2010J Clin Oncol2010,28,:1
16Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trim 显示文摘Cannas G Pautas C Raffoux E 2012LeukLymphoma2012,53,6:1
17Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after a llogeneic stem cell transplantation using fluorescence resonanace energy transfer hybridization probes显示文摘Costa JM Pautas C Ernault P 2000J Clin Microbiol2000,38,8:1
18Secondary antifun- gal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipi- ents显示文摘Cordonnier C Maury S Pautas C 2004Bone Marrow Transplant2004,33,9:1
19Infectious complications in adult acute myeloid leukemia analysis of the Acute Leuke- mia French Association-9802 prospective multicenter clinical trial显示文摘Cannas G Pautas C Raffoux E 2012Leuk Lymphoma2012,12,7:1
20Superior longterm outcome with idurabicin compared with highdose daunorubicin in patients with acute myeloid leukemia age 50years and older显示文摘Gardin C Chevret S Pautas C 2013J Clin Oncol2013,31,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费